Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P David Rogers

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
The Annals of Pharmacotherapy|December 23, 2011
Echinocandin use in the neonatal intensive care unitKelly E Caudle, Amanda G Inger, Dawn R Butler, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2009
An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicansClemens J Heilmann, Sabrina Schneider, Katherine S Barker, et al.
Antimicrobial Agents and Chemotherapy|June 18, 2014
SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1Bernardo Ramírez-Zavala, Selene Mogavero, Eva Schöller, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicansStephanie A Flowers, Brendan Colón, Sarah G Whaley, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic analysis of Mrr1p- and Tac1p-associated differential protein expression in azole-resistant clinical isolates of Candida albicansChristopher F Hoehamer, Edwin D Cummings, George M Hilliard, et al.
Cold Spring Harbor Perspectives in Medicine|November 12, 2014
Mechanisms of Antifungal Drug ResistanceLeah E Cowen, Dominique Sanglard, Susan J Howard, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 4, 2023
Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosisLaura A Doorley, Katherine S Barker, Qing Zhang, et al.
Pharmacotherapy|August 19, 2003
Effects of amphotericin B and caspofungin on histamine expressionJohn D Cleary, Michael Schwartz, P David Rogers, et al.
FEMS Yeast Research|May 25, 2010
Antimicrobial peptide MUC7 12-mer activates the calcium/calcineurin pathway in Candida albicansMaciej Lis, Teresa T Liu, Katherine S Barker, et al.
Eukaryotic Cell|March 25, 2014
UPC2 is universally essential for azole antifungal resistance in Candida albicansErin M Vasicek, Elizabeth L Berkow, Stephanie A Flowers, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
The Annals of Pharmacotherapy|December 23, 2011
Echinocandin use in the neonatal intensive care unitKelly E Caudle, Amanda G Inger, Dawn R Butler, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2009
An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicansClemens J Heilmann, Sabrina Schneider, Katherine S Barker, et al.
Antimicrobial Agents and Chemotherapy|June 18, 2014
SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1Bernardo Ramírez-Zavala, Selene Mogavero, Eva Schöller, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicansStephanie A Flowers, Brendan Colón, Sarah G Whaley, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic analysis of Mrr1p- and Tac1p-associated differential protein expression in azole-resistant clinical isolates of Candida albicansChristopher F Hoehamer, Edwin D Cummings, George M Hilliard, et al.
Cold Spring Harbor Perspectives in Medicine|November 12, 2014
Mechanisms of Antifungal Drug ResistanceLeah E Cowen, Dominique Sanglard, Susan J Howard, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 4, 2023
Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosisLaura A Doorley, Katherine S Barker, Qing Zhang, et al.
Pharmacotherapy|August 19, 2003
Effects of amphotericin B and caspofungin on histamine expressionJohn D Cleary, Michael Schwartz, P David Rogers, et al.
FEMS Yeast Research|May 25, 2010
Antimicrobial peptide MUC7 12-mer activates the calcium/calcineurin pathway in Candida albicansMaciej Lis, Teresa T Liu, Katherine S Barker, et al.
Eukaryotic Cell|March 25, 2014
UPC2 is universally essential for azole antifungal resistance in Candida albicansErin M Vasicek, Elizabeth L Berkow, Stephanie A Flowers, et al.
Pageof 11